Mesoblast CC Transcript 31/8, page-9

  1. 3,929 Posts.
    lightbulb Created with Sketch. 2779
    Trial controls.



    My take is we should do the trial this way

    Three groups of salvage therapy SR aGvHD patients

    Group 1 - gets product manufactured for the 001 trial
    Group 2 - gets product from a new manufacturing run, possibly the cells the FDA just observed during the Lonza inspection
    Group 3- Ruxolitinib/Best standard of care only

    1- verifies potency assay effectiveness in the trial lot
    2- verifies potency assay effectiveness in future lots
    3 - Demonstrates superior efficacy to Rux

    100 day survival outcomes , recruit 20 a month for three months


    That's my take on the CC comments , please correct me if I am on the wrong path


    Reg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.52
Change
-0.060(2.33%)
Mkt cap ! $3.225B
Open High Low Value Volume
$2.58 $2.61 $2.50 $12.63M 4.955M

Buyers (Bids)

No. Vol. Price($)
1 8366 $2.51
 

Sellers (Offers)

Price($) Vol. No.
$2.53 8780 4
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.